Curia global

Index
Globenewswire

Curia Recognized on India Pharma Outlook’s 2023 List of Top 10 CDMO Companies in India

Globenewswire

Curia Supports Replicate Bioscience’s Phase 1 Clinical Trial of Novel Next-Generation RNA Vaccine

Globenewswire

Curia Mendukung Uji Klinis Fase 1 Vaksin RNA Generasi Terbaru dari Replicate Bioscience

Globenewswire

Curia Tngkatkan Kemampuan Biologis dengan Akses ke Doggybone DNA dari Touchlight

Globenewswire

Curia Expands Biologics Capabilities with Access to Touchlight’s Doggybone DNA

Globenewswire

Curia Wins 2023 Frost & Sullivan Customer Value Leadership Award

Globenewswire

Curia Raih Penghargaan Customer Value Leadership 2023 dari Frost & Sullivan

Globenewswire

Curia Expands Cell Line Development Offering with CHOZN Platform

Globenewswire

Curia Perluas Penawaran Pengembangan Galur Sel dengan Platform CHOZN